IRIS
VISCIDO, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.235
EU - Europa 4.164
AS - Asia 4.147
SA - Sud America 559
AF - Africa 50
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.106
SG - Singapore 1.844
RU - Federazione Russa 1.003
IE - Irlanda 981
CN - Cina 854
BR - Brasile 471
DE - Germania 465
HK - Hong Kong 427
IT - Italia 403
TR - Turchia 400
VN - Vietnam 354
SE - Svezia 255
GB - Regno Unito 250
UA - Ucraina 227
FR - Francia 186
FI - Finlandia 180
CA - Canada 73
IN - India 69
AR - Argentina 43
CZ - Repubblica Ceca 43
JP - Giappone 41
MX - Messico 35
BE - Belgio 32
NL - Olanda 32
PL - Polonia 32
BD - Bangladesh 27
ID - Indonesia 23
ES - Italia 22
IQ - Iraq 22
ZA - Sudafrica 20
AT - Austria 12
LT - Lituania 11
PH - Filippine 11
CO - Colombia 10
EC - Ecuador 8
MA - Marocco 8
SA - Arabia Saudita 8
VE - Venezuela 8
JM - Giamaica 7
PE - Perù 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
JO - Giordania 6
KR - Corea 6
RO - Romania 6
BG - Bulgaria 5
IL - Israele 5
MY - Malesia 5
CL - Cile 4
EU - Europa 4
LB - Libano 4
PK - Pakistan 4
PT - Portogallo 4
TN - Tunisia 4
CH - Svizzera 3
CR - Costa Rica 3
EG - Egitto 3
GE - Georgia 3
PY - Paraguay 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BS - Bahamas 2
CD - Congo 2
CG - Congo 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BF - Burkina Faso 1
BM - Bermuda 1
BO - Bolivia 1
BT - Bhutan 1
CI - Costa d'Avorio 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
LK - Sri Lanka 1
LV - Lettonia 1
MW - Malawi 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
Totale 17.161
Salva come PNG Salva come JPEG
Città #
Singapore 998
Chandler 979
Dublin 971
Jacksonville 943
San Jose 856
Dallas 842
Ashburn 715
Hong Kong 422
Santa Clara 384
Boardman 321
The Dalles 225
Izmir 197
New York 192
Nanjing 159
Beijing 153
San Mateo 151
Lawrence 149
Princeton 149
Wilmington 142
Moscow 140
Council Bluffs 137
Ho Chi Minh City 121
Ann Arbor 114
Los Angeles 103
Munich 101
Hanoi 78
Lauterbourg 78
Dearborn 76
Milan 64
L'aquila 62
São Paulo 61
Bremen 50
Hefei 45
Helsinki 42
Woodbridge 42
Columbus 40
Des Moines 39
Seattle 39
Brno 38
Nanchang 37
Shenyang 37
Frankfurt am Main 36
Tokyo 35
Turku 33
Brussels 32
Rome 32
Tianjin 32
Verona 32
Kunming 31
Orem 31
Warsaw 30
Berlin 28
London 28
Montreal 28
Shanghai 28
Phoenix 27
Jinan 25
Norwalk 24
Lappeenranta 22
Poplar 22
Chennai 21
Amsterdam 20
Stockholm 20
Boston 19
Mumbai 19
Brooklyn 18
Jiaxing 18
Rio de Janeiro 18
Toronto 18
Zhengzhou 18
Haiphong 16
Hebei 16
Belo Horizonte 15
Falkenstein 15
Brasília 14
L’Aquila 14
Mexico City 14
San Francisco 14
Chicago 13
Denver 13
Manchester 13
Mountain View 13
Pescara 13
Changsha 12
Dong Ket 12
Atlanta 11
Fairfield 11
Ankara 10
Biên Hòa 10
Florence 10
Jakarta 10
Ningbo 10
Da Nang 9
Fremont 9
Guangzhou 9
Hangzhou 9
Johannesburg 9
Baghdad 8
Changchun 8
Vienna 7
Totale 11.584
Salva come PNG Salva come JPEG
Nome #
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 335
The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study 247
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 182
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 177
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 166
Histological healing in ulcerative colitis with mesalazine and its prognostic role 159
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 157
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 156
Association between colonic diverticula and colorectal polyps and cancer 151
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 148
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 147
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis 146
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 145
Association between colorectal polyps and colonic diverticulosis 144
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 140
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 140
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies 137
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 133
GI distension in severe ulcerative colitis 131
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 130
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 129
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 129
SpA plus IBD or IBD plus SpA: Does commutative property apply? 128
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 127
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 127
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 126
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. 125
Persistent iron deficiency anemia in patients with celiac disease despite a gluten-free diet 125
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 124
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis 124
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients 123
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 123
Are volatile organic compounds accurate markers in the assessment of colorectal cancer and inflammatory bowel diseases? A review 123
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 122
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 121
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 121
The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics 121
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literature 120
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 120
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. 119
Mucosal healing: Mayo 0 vs 1 after 3 years. 119
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 119
Current management of severe ulcerative colitis. 119
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 119
Duodenal lymphocytosis in functional dyspepsia 118
Celiac disease, gluten-free diet, and metabolic and liver disorders 117
Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients 116
Association of colonic diverticula with colorectal adenomas and cancer 115
Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-Term Clinical Outcomes from a Population-Based Study 114
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 114
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 114
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications 113
Is mesalazine treatment effective in the prevention of diverticulitis? A review 112
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 112
Nanotechnology in the treatment of inflammatory bowel diseases. 112
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 111
NK activity and antibody-dependent cellular citotoxicity (ADCC) in inflammatory bowel disease(IBD) 110
In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. 110
Safe use of infliximab for the treatment of fistulizing Crohn’s disease during pregnancy within 3 months of conception. 110
Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered 109
Acute colitis following colonoscopy 109
Persistence of anemia in patients with Celiac disease despite a gluten free diet: a retrospective study 108
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 107
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 107
MRI EVALUATION OF CROHN DISEASE OF THE SMALL AND LARGE BOWEL USING NEGATIVE SUPERPARAMAGNETIC CONTRAST AGENT 107
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 107
The role on endoscopy in alcohol-related diseases 107
Dietary factors modulating colorectal carcinogenesis 107
Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet 107
Prognostic factors for post-operative recurrence of Crohn's disease 106
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 105
Acute colitis following endoscopy: an outbreak of three cases 105
L’intestino nei pazienti critici. La barriera mucosa intestinale e le sue alterazioni (prima parte). Giornale di Gastroenterologia 1998; 3: 70-103 105
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 104
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 104
Colonic mucosal concentration of 5-ASA in ulcerative colitis. 103
Unmet medical needs in the management of ulcerative colitis: Results of an Italian delphi consensus 103
Quinidine-induced colitis. Report of three cases. 102
Small intestine contrast ultrasonography: An alternative to radiology in the assessment of small bowel disease 102
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. 101
Recidive stenosanti ricorrenti nel morbo di Crohn. Giornale di Gastroenterologia, 1999, 4: 150-155 101
The long-term effect on surgery-free survival of biological compared to conventional therapy in Crohn's disease in real world-data: a retrospective study 101
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. 100
Effectiveness of Vitamin D Supplementation on Disease Course in Inflammatory Bowel Disease Patients: Systematic Review With Meta-Analysis 98
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 98
Value of T2-weighted fat suppressed and non suppressed sequences after oral administration of a superparamagnetic contrast agent in the assessmento of Crohn's disease activity 98
A new technique of magnetic resonance imaging (MRI) in the management of patients with Crohn's disease. 98
Linfociti circolanti gamma-delta in corso di malattie infiammatorie intestinali. 97
Il 5-ASA (ASACOL) previene le recidive post-operatorie del morbo di crohn (MC): risultati dello studio GISC a tre anni di follow-up. 97
Evaluation of Crohn disease activity with magnetic resonance imaging 97
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A pragmatic double blind randomised controlled trial . Aliment Pharmacol Ther 2003;17:517-523 97
An unusual treatment for a colonic polyp. 96
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A double blind randomised clinical trial. AGISC study. 96
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 96
A mathematical model to study natural history of crohn’s disease. 95
Wegener's granulomatosis and retroperitoneal fibrosis: A case report and review of the literature 95
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 95
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 94
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. 94
Gastrointestinal distension in severe ulcerative colitis 93
Totale 12.073
Salva come PNG Salva come JPEG
Categoria #
all - tutte 72.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.879
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021269 0 0 0 0 0 0 0 0 0 0 232 37
2021/2022799 34 60 94 39 32 27 12 58 43 32 68 300
2022/20232.841 216 159 44 293 257 301 0 204 1.233 16 84 34
2023/2024990 98 28 29 91 47 167 30 285 4 39 51 121
2024/20253.074 69 50 288 98 298 317 382 265 686 180 222 219
2025/20266.168 253 640 602 759 627 452 1.021 217 582 816 199 0
Totale 17.411